DIABETIC DYSLIPIDEMIA AND ATHEROSCLEROSIS

被引:0
|
作者
SHEPHERD, J
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non insulin-dependent diabetes mellitus is frequently accompanied by qualitative and quantitative abnormalities in plasma lipids and lipoproteins, Increased triglycerides and decreased HDL (high density lipoprotein)-cholesterol are commonly observed; these alterations are recognized risk factors for coronary heart disease. Moderately elevated plasma triglyceride-rich liproproteins may contribute to the atherogenic process through remodelling of LDL (low density liproprotein) and HDL particles. Good glycemic control, diet and, when necessary, treatment with fibrates will correct or partially reverse the abnormal lipoprotein profiles found in diabetic patients.
引用
收藏
页码:1933 / 1937
页数:5
相关论文
共 50 条
  • [21] Treatment of diabetic dyslipidemia
    Garg, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A): : 47B - 51B
  • [22] Management of diabetic dyslipidemia
    Solano, MD
    Goldberg, RB
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2005, 34 (01) : 1 - +
  • [23] Dyslipidemia and diabetic neuropathy
    Feldman, E. L.
    Vincent, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S51 - S51
  • [24] Diabetic ketosis and dyslipidemia
    Gaigi, I.
    Falfoul, E.
    Fendi, O.
    Doghri, S.
    Khadhraoui, E.
    Amrouche, C.
    Jamoussi, H.
    Blouza, S.
    DIABETES & METABOLISM, 2011, 37 : A82 - A82
  • [25] Dyslipidemia in diabetic nephropathy
    Kawanami D.
    Matoba K.
    Utsunomiya K.
    Renal Replacement Therapy, 2 (1)
  • [26] Pathophysiology of Diabetic Dyslipidemia
    Hirano, Tsutomu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (09) : 771 - 782
  • [27] TREATMENT OF DIABETIC DYSLIPIDEMIA
    DENKE, MA
    GRUNDY, SM
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (01) : 56 - 58
  • [28] Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor
    Johnson, Lance A.
    Arbones-Mainar, Jose M.
    Fox, Raymond G.
    Pendse, Avani A.
    Altenburg, Michael K.
    Kim, Hyung-Suk
    Maeda, Nobuyo
    DIABETES, 2011, 60 (09) : 2285 - 2294
  • [29] CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic Dyslipidemia and Atherosclerosis
    Geloen, Alain
    Helin, Lionel
    Geeraert, Benjamine
    Malaud, Eric
    Holvoet, Paul
    Marguerie, Gerard
    PLOS ONE, 2012, 7 (05):
  • [30] Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia
    Dake, Andrew W.
    Sora, Nicoleta D.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (04): : 361 - 365